1
|
Nardella F, Dobrescu I, Hassan H, Rodrigues F, Thiberge S, Mancio-Silva L, Tafit A, Jallet C, Cadet-Daniel V, Goussin S, Lorthiois A, Menon Y, Molinier N, Pechalrieu D, Long C, Sautel F, Matondo M, Duchateau M, Médard G, Witkowski B, Scherf A, Halby L, Arimondo PB. Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum. iScience 2023; 26:105940. [PMID: 36718363 PMCID: PMC9883252 DOI: 10.1016/j.isci.2023.105940] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 12/23/2022] [Accepted: 01/05/2023] [Indexed: 01/13/2023] Open
Abstract
Malaria eradication requires the development of new drugs to combat drug-resistant parasites. We identified bisbenzylisoquinoline alkaloids isolated from Cocculus hirsutus that are active against Plasmodium falciparum blood stages. Synthesis of a library of 94 hemi-synthetic derivatives allowed to identify compound 84 that kills multi-drug resistant clinical isolates in the nanomolar range (median IC50 ranging from 35 to 88 nM). Chemical optimization led to compound 125 with significantly improved preclinical properties. 125 delays the onset of parasitemia in Plasmodium berghei infected mice and inhibits P. falciparum transmission stages in vitro (culture assays), and in vivo using membrane feeding assay in the Anopheles stephensi vector. Compound 125 also impairs P. falciparum development in sporozoite-infected hepatocytes, in the low micromolar range. Finally, by chemical pull-down strategy, we characterized the parasite interactome with trilobine derivatives, identifying protein partners belonging to metabolic pathways that are not targeted by the actual antimalarial drugs or implicated in drug-resistance mechanisms.
Collapse
Affiliation(s)
- Flore Nardella
- Biology of Host-Parasite Interaction, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris-Cité, CNRS EMR 9195, INSERM Unit U1201, 25-28 Rue du Dr Roux, 75015 Paris, France
| | - Irina Dobrescu
- Biology of Host-Parasite Interaction, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris-Cité, CNRS EMR 9195, INSERM Unit U1201, 25-28 Rue du Dr Roux, 75015 Paris, France
| | - Haitham Hassan
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Fabien Rodrigues
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Sabine Thiberge
- Biology of Host-Parasite Interaction, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris-Cité, CNRS EMR 9195, INSERM Unit U1201, 25-28 Rue du Dr Roux, 75015 Paris, France,Center for Production and Infection of Anopheles (CEPIA), Center for Animal Resources and Research, Institut Pasteur, 75015 Paris, France
| | - Liliana Mancio-Silva
- Biology of Host-Parasite Interaction, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris-Cité, CNRS EMR 9195, INSERM Unit U1201, 25-28 Rue du Dr Roux, 75015 Paris, France
| | - Ambre Tafit
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Corinne Jallet
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Véronique Cadet-Daniel
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Stéphane Goussin
- Center for Production and Infection of Anopheles (CEPIA), Center for Animal Resources and Research, Institut Pasteur, 75015 Paris, France
| | - Audrey Lorthiois
- Center for Production and Infection of Anopheles (CEPIA), Center for Animal Resources and Research, Institut Pasteur, 75015 Paris, France
| | - Yoann Menon
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Nicolas Molinier
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Dany Pechalrieu
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Christophe Long
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - François Sautel
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Mariette Matondo
- Proteomics Platform, Mass Spectrometry for Biology Unit, Institut Pasteur, Université de Paris-Cité, CNRS USR 2000, 28 rue du Dr Roux, 75015 Paris, France
| | - Magalie Duchateau
- Proteomics Platform, Mass Spectrometry for Biology Unit, Institut Pasteur, Université de Paris-Cité, CNRS USR 2000, 28 rue du Dr Roux, 75015 Paris, France
| | - Guillaume Médard
- Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, 85354 Freising, Germany
| | - Benoit Witkowski
- Malaria Molecular Epidemiology Unit, Pasteur Institute in Cambodia, Phnom Penh 12201, Cambodia
| | - Artur Scherf
- Biology of Host-Parasite Interaction, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris-Cité, CNRS EMR 9195, INSERM Unit U1201, 25-28 Rue du Dr Roux, 75015 Paris, France,Corresponding author
| | - Ludovic Halby
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France
| | - Paola B. Arimondo
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université de Paris-Cité, UMR n°3523, CNRS, 28 Rue du Dr Roux, 75015 Paris, France,USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France,Corresponding author
| |
Collapse
|
2
|
Lecourt C, Dhambri S, Yamani K, Boissonnat G, Specklin S, Fleury E, Hammad K, Auclair E, Sablé S, Grondin A, Arimondo PB, Sautel F, Massiot G, Meyer C, Cossy J, Sorin G, Lannou M, Ardisson J. Assembly of the Entire Carbon Backbone of a Stereoisomer of the Antitumor Marine Natural Product Hemicalide. Chemistry 2019; 25:2745-2749. [DOI: 10.1002/chem.201806327] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2018] [Indexed: 12/15/2022]
Affiliation(s)
- Camille Lecourt
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Sabrina Dhambri
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| | - Khalil Yamani
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Guillaume Boissonnat
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Simon Specklin
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Etienne Fleury
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| | - Karim Hammad
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| | - Eric Auclair
- Sanofi R&D Centre de Recherche de Vitry-Alfortville 13 quai Jules Guesde 94403 Vitry-sur-Seine Cedex France
| | - Serge Sablé
- Sanofi R&D Centre de Recherche de Vitry-Alfortville 13 quai Jules Guesde 94403 Vitry-sur-Seine Cedex France
| | - Antonio Grondin
- Pharmacochimie de la Régulation Epigénétique du Cancer (ETac) CNRS–Pierre Fabre (USR3388) 3 avenue Hubert Curien 31035 Toulouse Cedex 01 France
| | - Paola B. Arimondo
- Pharmacochimie de la Régulation Epigénétique du Cancer (ETac) CNRS–Pierre Fabre (USR3388) 3 avenue Hubert Curien 31035 Toulouse Cedex 01 France
| | - François Sautel
- Pharmacochimie de la Régulation Epigénétique du Cancer (ETac) CNRS–Pierre Fabre (USR3388) 3 avenue Hubert Curien 31035 Toulouse Cedex 01 France
| | - Georges Massiot
- Pharmacochimie de la Régulation Epigénétique du Cancer (ETac) CNRS–Pierre Fabre (USR3388) 3 avenue Hubert Curien 31035 Toulouse Cedex 01 France
| | - Christophe Meyer
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Janine Cossy
- Laboratory of Organic Chemistry Chemistry, Biology, Innovation ESPCI Paris, CNRS (UMR8231) PSL Research University 10 rue Vauquelin 75231 Paris Cedex 05 France
| | - Geoffroy Sorin
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| | - Marie‐Isabelle Lannou
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| | - Janick Ardisson
- CNRS (UMR8638) Faculté de Pharmacie Université Paris Descartes 4 avenue de l'observatoire 75270 Paris Cedex 06 France
| |
Collapse
|
3
|
Maiga-Wandiam B, Corbu A, Massiot G, Sautel F, Yu P, Lin BWY, Houk KN, Cossy J. Intramolecular Diels–Alder Approaches to the Decalin Core of Verongidolide: The Origin of the exo-Selectivity, a DFT Analysis. J Org Chem 2018; 83:5975-5985. [DOI: 10.1021/acs.joc.8b00566] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Baba Maiga-Wandiam
- Laboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL Research University, CNRS, 10 rue Vauquelin, 75231 - Paris Cedex 05, France
| | - Andrei Corbu
- Laboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL Research University, CNRS, 10 rue Vauquelin, 75231 - Paris Cedex 05, France
| | - Georges Massiot
- Université de Reims Champagne-Ardenne, Institut de Chimie Moléculaire de Reims, CNRS, UFR des Sciences Exactes et Naturelles, Campus Sciences, Moulin de la Housse, 51687 - Reims Cedex 2, France
| | - François Sautel
- CNRS/Pierre Fabre USR 3388, Centre de Recherche et Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 - Toulouse Cedex 01, France
| | - Peiyuan Yu
- Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90065, United States
| | - Bernice Wan-Yi Lin
- Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90065, United States
| | - Kendall N. Houk
- Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90065, United States
| | - Janine Cossy
- Laboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), ESPCI Paris, PSL Research University, CNRS, 10 rue Vauquelin, 75231 - Paris Cedex 05, France
| |
Collapse
|
4
|
Rodrigues AM, Rohée C, Fabre T, Batailler N, Sautel F, Carletti I, Nogues S, Suzuki MT, Stien D. Cytotoxic indole alkaloids from Pseudovibrio denitrificans BBCC725. Tetrahedron Lett 2017. [DOI: 10.1016/j.tetlet.2017.07.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
5
|
Lecourt C, Boinapally S, Dhambri S, Boissonnat G, Meyer C, Cossy J, Sautel F, Massiot G, Ardisson J, Sorin G, Lannou MI. Elaboration of Sterically Hindered δ-Lactones through Ring-Closing Metathesis: Application to the Synthesis of the C1–C27 Fragment of Hemicalide. J Org Chem 2016; 81:12275-12290. [DOI: 10.1021/acs.joc.6b02208] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Camille Lecourt
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| | - Srikanth Boinapally
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| | - Sabrina Dhambri
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| | - Guillaume Boissonnat
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI Paris, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Christophe Meyer
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI Paris, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Janine Cossy
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI Paris, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - François Sautel
- Pharmacochimie
de la Régulation Epigénétique du Cancer (ETac),
CNRS/Pierre Fabre (USR3388), Centre de Recherche et de Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Georges Massiot
- Pharmacochimie
de la Régulation Epigénétique du Cancer (ETac),
CNRS/Pierre Fabre (USR3388), Centre de Recherche et de Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Janick Ardisson
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| | - Geoffroy Sorin
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| | - Marie-Isabelle Lannou
- Laboratoire
Synthèse et Méthodes, Faculté de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’Observatoire, 75270 Paris Cedex 06, France
| |
Collapse
|
6
|
Specklin S, Boissonnat G, Lecourt C, Sorin G, Lannou MI, Ardisson J, Sautel F, Massiot G, Meyer C, Cossy J. Synthetic Studies toward the C32–C46 Segment of Hemicalide. Assignment of the Relative Configuration of the C36–C42 Subunit. Org Lett 2015; 17:2446-9. [DOI: 10.1021/acs.orglett.5b00955] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Simon Specklin
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI ParisTech, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Guillaume Boissonnat
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI ParisTech, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Camille Lecourt
- Faculté
de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Geoffroy Sorin
- Faculté
de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Marie-Isabelle Lannou
- Faculté
de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Janick Ardisson
- Faculté
de Pharmacie, Université Paris Descartes, CNRS (UMR8638), 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - François Sautel
- Pharmacochimie de
la Régulation Epigénétique du Cancer (ETac),
CNRS/Pierre Fabre (USR3388), Centre de Recherche et de Développement
Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Georges Massiot
- Pharmacochimie de
la Régulation Epigénétique du Cancer (ETac),
CNRS/Pierre Fabre (USR3388), Centre de Recherche et de Développement
Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Christophe Meyer
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI ParisTech, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Janine Cossy
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI), ESPCI ParisTech, CNRS (UMR8231), PSL Research University, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| |
Collapse
|
7
|
Rahier NJ, Molinier N, Long C, Deshmukh SK, Kate AS, Ranadive P, Verekar SA, Jiotode M, Lavhale RR, Tokdar P, Balakrishnan A, Meignan S, Robichon C, Gomes B, Aussagues Y, Samson A, Sautel F, Bailly C. Anticancer activity of koningic acid and semisynthetic derivatives. Bioorg Med Chem 2015; 23:3712-21. [PMID: 25937235 DOI: 10.1016/j.bmc.2015.04.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2015] [Revised: 03/28/2015] [Accepted: 04/02/2015] [Indexed: 10/23/2022]
Abstract
A screening program aimed at discovering novel anticancer agents based on natural products led to the selection of koningic acid (KA), known as a potent inhibitor of glycolysis. A method was set up to produce this fungal sesquiterpene lactone in large quantities by fermentation, thus allowing (i) an extensive analysis of its anticancer potential in vitro and in vivo and (ii) the semi-synthesis of analogues to delineate structure-activity relationships. KA was characterized as a potent, but non-selective cytotoxic agent, active under both normoxic and hypoxic conditions and inactive in the A549 lung cancer xenograft model. According to our SAR, the acidic group could be replaced to keep bioactivity but an intact epoxide is essential.
Collapse
Affiliation(s)
- Nicolas J Rahier
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France.
| | - Nicolas Molinier
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Christophe Long
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Sunil Kumar Deshmukh
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Abhijeet S Kate
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Prafull Ranadive
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Shilpa Amit Verekar
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Mangesh Jiotode
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Rahul R Lavhale
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Pradipta Tokdar
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Arun Balakrishnan
- Piramal Enterprises Limited, 1 Nirlon Complex, Off Western Express Highway, Goregaon East, Mumbai, Maharashtra 400 063, India
| | - Samuel Meignan
- Antitumoral Pharmacology Unit, Centre Oscar Lambret, Inserm U908, BP 307, 59020 Lille cedex, France
| | - Céline Robichon
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Bruno Gomes
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Yannick Aussagues
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Arnaud Samson
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - François Sautel
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France
| | - Christian Bailly
- Institut de Recherche Pierre Fabre, Centre de Recherche et Développement, 3 Avenue Hubert Curien-BP 13562, 31035 Toulouse cedex 1, France.
| |
Collapse
|
8
|
Pouny I, Batut M, Vendier L, David B, Yi S, Sautel F, Arimondo PB, Massiot G. Cytisine-like alkaloids from Ormosia hosiei Hemsl. & E.H. Wilson. Phytochemistry 2014; 107:97-101. [PMID: 25172516 DOI: 10.1016/j.phytochem.2014.07.022] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Revised: 07/22/2014] [Accepted: 07/23/2014] [Indexed: 06/03/2023]
Abstract
Four alkaloids named hosieines A-D were isolated from the root and stem of Ormosia hosiei. Their flat structures were established by mass spectrometry and by a combination of NMR experiments. These molecules probably share a common biosynthetic origin with the lupin alkaloids but they differ in the formation of the last ring, being here part of a rare 2-azabicyclo[3.2.1]octane system. Their absolute configuration was determined by X-ray crystallography using CuKα radiation. As has been described for cytisine, they display a remarkable affinity towards neuronal nicotinic acetylcholine α4β2 receptor.
Collapse
Affiliation(s)
- Isabelle Pouny
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Muriel Batut
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Laure Vendier
- UPR CNRS No. 8241, Laboratoire de Chimie de Coordination, 205 route de Narbonne, 31077 Toulouse Cedex 04, France
| | - Bruno David
- Pôle Actifs Végétaux, Institut de Recherche Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Sirong Yi
- Chongqing Institute of Medicinal Plant Cultivation, Sanquan Country of Nanchuang, 408435 Chongqing, PR China
| | - François Sautel
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Paola B Arimondo
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Georges Massiot
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France.
| |
Collapse
|
9
|
|
10
|
Rilova E, Erdmann A, Gros C, Masson V, Aussagues Y, Poughon-Cassabois V, Rajavelu A, Jeltsch A, Menon Y, Novosad N, Gregoire JM, Vispé S, Schambel P, Ausseil F, Sautel F, Arimondo PB, Cantagrel F. Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation. ChemMedChem 2014; 9:590-601. [PMID: 24678024 PMCID: PMC4506529 DOI: 10.1002/cmdc.201300420] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Quinoline derivative SGI-1027 (N-(4-(2-amino-6-methylpyrimidin-4-ylamino)phenyl)-4-(quinolin-4-ylamino)benzamide) was first described in 2009 as a potent inhibitor of DNA methyltransferase (DNMT) 1, 3A and 3B. Based on molecular modeling studies, performed using the crystal structure of Haemophilus haemolyticus cytosine-5 DNA methyltransferase (MHhaI C5 DNMT), which suggested that the quinoline and the aminopyridimine moieties of SGI-1027 are important for interaction with the substrates and protein, we designed and synthesized 25 derivatives. Among them, four compounds—namely the derivatives 12, 16, 31 and 32—exhibited activities comparable to that of the parent compound. Further evaluation revealed that these compounds were more potent against human DNMT3A than against human DNMT1 and induced the re-expression of a reporter gene, controlled by a methylated cytomegalovirus (CMV) promoter, in leukemia KG-1 cells. These compounds possessed cytotoxicity against leukemia KG-1 cells in the micromolar range, comparable with the cytotoxicity of the reference compound, SGI-1027. Structure–activity relationships were elucidated from the results. First, the presence of a methylene or carbonyl group to conjugate the quinoline moiety decreased the activity. Second, the size and nature of the aromatic or heterocycle subsitutents effects inhibition activity: tricyclic moieties, such as acridine, were found to decrease activity, while bicyclic substituents, such as quinoline, were well tolerated. The best combination was found to be a bicyclic substituent on one side of the compound, and a one-ring moiety on the other side. Finally, the orientation of the central amide bond was found to have little effect on the biological activity. This study provides new insights in to the structure-activity relationships of SGI-1027 and its derivative.
Collapse
Affiliation(s)
- Elodie Rilova
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Alexandre Erdmann
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Christina Gros
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Véronique Masson
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Yannick Aussagues
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Valérie Poughon-Cassabois
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Arumugam Rajavelu
- Institute of Biochemistry, Faculty of Chemistry, University StuttgartPfaffenwaldring 55, 70569 Stuttgart (Germany)
| | - Albert Jeltsch
- Institute of Biochemistry, Faculty of Chemistry, University StuttgartPfaffenwaldring 55, 70569 Stuttgart (Germany)
| | - Yoann Menon
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Natacha Novosad
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Jean-Marc Gregoire
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Stéphane Vispé
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Philippe Schambel
- Institut de Recherches Pierre Fabre17 Rue Jean Moulin, 81106 Castres Cedex (France)
| | - Fréderic Ausseil
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - François Sautel
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Paola B Arimondo
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| | - Frédéric Cantagrel
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et de Développement Pierre Fabre (CRDPF)3 Ave Hubert Curien, 31035 Toulouse Cedex 01 (France) E-mail:
| |
Collapse
|
11
|
Long C, Aussagues Y, Molinier N, Marcourt L, Vendier L, Samson A, Poughon V, Chalo Mutiso PB, Ausseil F, Sautel F, Arimondo PB, Massiot G. Dichapetalins from Dichapetalum species and their cytotoxic properties. Phytochemistry 2013; 94:184-191. [PMID: 23618620 DOI: 10.1016/j.phytochem.2013.03.023] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2012] [Revised: 03/27/2013] [Accepted: 03/29/2013] [Indexed: 06/02/2023]
Abstract
Six dichapetalins named dichapetalins N-S were isolated from Dichapetalum mombuttense, Dichapetalum zenkeri and Dichapetalum leucosia. They were accompanied in the same plants by the known dichapetalins A, B, C, I, L and M. The structures of the compounds were elucidated by 1D and 2D NMR experiments and mass spectrometry. They all possessed the dammarane skeleton substituted at position C-3 by a C6-C2 unit forming a 2-phenylpyran moiety. All contained a lactone ring in the side chain except dichapetalins O, Q and R, in which this ring was replaced by a lactol. Dichapetalin Q and R were also the first dichapetalins bearing a tertiary methyl and a double bond instead of the cyclopropane of the dammaranes. All these compounds were assayed against cancer cell lines HCT116 and WM 266-4 and displayed cytotoxic and anti-proliferative activities in the 10(-6) to 10(-8)M range.
Collapse
Affiliation(s)
- Christophe Long
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Sorin G, Fleury E, Tran C, Prost E, Molinier N, Sautel F, Massiot G, Specklin S, Meyer C, Cossy J, Lannou MI, Ardisson J. Synthetic Studies on Hemicalide: Development of a Convergent Approach toward the C1–C25 Fragment. Org Lett 2013; 15:4734-7. [DOI: 10.1021/ol402077e] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Geoffroy Sorin
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Etienne Fleury
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Christine Tran
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Elise Prost
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Nicolas Molinier
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - François Sautel
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Georges Massiot
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Simon Specklin
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Christophe Meyer
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Janine Cossy
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Marie-Isabelle Lannou
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| | - Janick Ardisson
- Faculté de Pharmacie, Université Paris Descartes, CNRS UMR 8638, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France, CNRS−Pierre Fabre USR 3388, Centre de Recherche & Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France, and Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS UMR 7084, 10 rue Vauquelin, 75231 Paris Cedex 05, France
| |
Collapse
|
13
|
Fleury E, Sorin G, Prost E, Pancrazi A, Sautel F, Massiot G, Lannou MI, Ardisson J. Relative Stereochemical Determination and Synthesis of the C17–C25 δ-Lactone Fragment of Hemicalide. J Org Chem 2013; 78:855-64. [DOI: 10.1021/jo302440a] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Etienne Fleury
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Geoffroy Sorin
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Elise Prost
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Ange Pancrazi
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - François Sautel
- CNRS/Pierre Fabre USR 3388, Centre de Recherche et Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Georges Massiot
- CNRS/Pierre Fabre USR 3388, Centre de Recherche et Développement Pierre Fabre, 3 avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | - Marie-Isabelle Lannou
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| | - Janick Ardisson
- CNRS UMR 8638, Faculté
de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris Cedex 06, France
| |
Collapse
|
14
|
Long C, Beck J, Cantagrel F, Marcourt L, Vendier L, David B, Plisson F, Derguini F, Vandenberghe I, Aussagues Y, Ausseil F, Lavaud C, Sautel F, Massiot G. Proteasome inhibitors from Neoboutonia melleri. J Nat Prod 2012; 75:34-47. [PMID: 22168134 DOI: 10.1021/np200441h] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Thirty new cycloartane derivatives (1-3, 5-12, 14-32) have been isolated from the leaves of Neoboutonia melleri. Their novelty stems from the loss of one of the C-4 methyl groups (1-3, 5-12, 14-25, and 32) and from the presence of an "extra" carbon atom in the side chain (1-3, 5-12, 14-20, 26-29, and 30-32). Furthermore, compound 32 possesses a rare triterpene skeleton with the cyclopropane ring fused onto C-1 and C-10, instead of C-9 and C-10. The structures were determined by spectrometric means, chemical correlations, and X-ray crystallography of derivative 1c. The substitution pattern in ring A, with a cyclopropyl ring conjugated with an α,β-unsaturated carbonyl moiety, confers to the molecule a particular reactivity, giving rise to a formal inversion of the stereochemistry of the cyclopropane ring under UV irradiation. These compounds showed an interesting level of activity on the proteasome pathway, thus motivating their evaluation as possible anticancer agents. The large number of isolated compounds permitted a structure-activity relationship analysis, which showed that the presence of the two enone functions was a requirement for the activity.
Collapse
Affiliation(s)
- Christophe Long
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Beck J, Guminski Y, Long C, Marcourt L, Derguini F, Plisson F, Grondin A, Vandenberghe I, Vispé S, Brel V, Aussagues Y, Ausseil F, Arimondo PB, Massiot G, Sautel F, Cantagrel F. Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors. Bioorg Med Chem 2011; 20:819-31. [PMID: 22206869 DOI: 10.1016/j.bmc.2011.11.066] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2011] [Revised: 11/25/2011] [Accepted: 11/29/2011] [Indexed: 12/18/2022]
Abstract
The interesting pharmacological properties of neoboutomellerones 1 and 2 were the basis for the assembly of a small library of analogues consisting of natural products isolated from the plant Neoboutonia melleri and of semisynthetic derivatives. As the two enone systems (C23-C24a and C1-C3) and the two hydroxyls groups (C22 and C26) of neoboutomellerones are required for activity, modifications were focused on these functional groups. Biological evaluation by using a cellular assay for proteasome activity provided clues regarding the mechanism of action of these natural products and synthetic derivatives. Certain neoboutomellerone derivatives inhibited the proliferation of human WM-266-4 melanoma tumor cells at submicromolar concentration and warrant evaluation as anticancer agents.
Collapse
Affiliation(s)
- Joséphine Beck
- USR CNRS-Pierre Fabre No. 3388 ETaC, Centre de Recherche et Développement Pierre Fabre, 3 Avenue Hubert Curien, 31035 Toulouse Cedex 01, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Pouny I, Vispé S, Marcourt L, Long C, Vandenberghe I, Aussagues Y, Raux R, Chalo Mutiso PB, Massiot G, Sautel F. Four new carvotanacetone derivatives from Sphaeranthus ukambensis, inhibitors of the ubiquitin-proteasome pathway. Planta Med 2011; 77:1605-1609. [PMID: 21425033 DOI: 10.1055/s-0030-1270935] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Six carvotanacetone derivatives (1- 6), amongst which four new compounds (1- 4), were isolated from the aerial parts of Sphaeranthus ukambensis Vatke & O. Hoffm. The structures of the molecules were elucidated by complementary spectroscopic methods, and their biological properties were investigated using human DLD-1 colon cancer cells engineered to stably express a 4 ubiquitin-luciferase (4 Ub-Luc) reporter protein. Five of the isolated carvotanacetone derivatives (2- 6) were found to inhibit the proliferation of the colon cancer cells and interfere with the ubiquitin-proteasome pathway, with potencies in a micromolar range.
Collapse
Affiliation(s)
- Isabelle Pouny
- Unité Mixte de Service 2597, Centre National de la Recherche Scientifique (CNRS)-Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse, Toulouse, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Fleury E, Lannou MI, Bistri O, Sautel F, Massiot G, Pancrazi A, Ardisson J. Advances in the Universal NMR Database: Toward the Determination of the Relative Configurations of Large Polypropionates. European J Org Chem 2009. [DOI: 10.1002/ejoc.200900616] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|
18
|
Fleury E, Lannou MI, Bistri O, Sautel F, Massiot G, Pancrazi A, Ardisson J. Relative Stereochemical Determination and Synthesis of the C1−C17 Fragment of a New Natural Polyketide. J Org Chem 2009; 74:7034-45. [DOI: 10.1021/jo9012833] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Etienne Fleury
- CNRS UMR 8638, Faculté de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris cedex 06, France
| | - Marie-Isabelle Lannou
- CNRS UMR 8638, Faculté de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris cedex 06, France
| | - Olivia Bistri
- CNRS UMR 8638, Faculté de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris cedex 06, France
| | - François Sautel
- CNRS/Pierre Fabre UMS 2597, Laboratoire Pierre Fabre, 3 rue des satellites, BP 94244, 31402 Toulouse cedex 4, France
| | - Georges Massiot
- CNRS/Pierre Fabre UMS 2597, Laboratoire Pierre Fabre, 3 rue des satellites, BP 94244, 31402 Toulouse cedex 4, France
| | - Ange Pancrazi
- CNRS UMR 8638, Faculté de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris cedex 06, France
| | - Janick Ardisson
- CNRS UMR 8638, Faculté de Pharmacie, Université Paris Descartes, 4 avenue de l’observatoire, 75270 Paris cedex 06, France
| |
Collapse
|
19
|
Assié MB, Bardin L, Auclair A, Consul-Denjean N, Sautel F, Depoortère R, Newman-Tancredi A. F15063, a potential antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice. Naunyn Schmiedebergs Arch Pharmacol 2007; 375:241-50. [PMID: 17453175 DOI: 10.1007/s00210-007-0162-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2006] [Accepted: 03/26/2007] [Indexed: 01/18/2023]
Abstract
F15063 (N-[(2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl]-3-(cyclopent-1-enyl)-benzylamine fumarate salt) is a novel potential antipsychotic with dopamine D(2)/D(3) blocking properties and agonist activity at 5-HT(1A) and D(4) receptors. The pertinent parameter for pharmacological activity of antipsychotics appears to be central D2-like receptor occupancy. However, its duration is not necessarily correlated with drug plasma levels, on which clinical dosing regimens are often based. Thus, we compared in mice the duration of actions of F15063 and haloperidol to (1) inhibit apomorphine-induced climbing and sniffing (behavioural measures of D2-like receptor antagonism) and (2) occupy D2-like receptors in vivo in the striatum and olfactory tubercles (inhibition of [(3)H]nemonapride binding). Finally, we measured plasma levels of F15063. D2-like receptor occupancy in the striatum remained elevated at 1, 4 and 8 h postadministration, with both F15063 (ID(50): 7.1, 3.6 and 16.5 mg/kg p.o., respectively) and the typical antipsychotic, haloperidol (ID(50): 1.4, 0.52 and 0.53 mg/kg p.o., respectively). This was paralleled by a protracted inhibition of apomorphine-induced climbing (ED(50): 0.9, 2.8 and 3.6 mg/kg p.o., and 0.21, 0.37 and 0.87 mg/kg p.o., respectively, for F15063 and haloperidol). In contrast, after administration of 10 mg/kg p.o. of F15063, its plasma levels decreased rapidly: 15.2, 2.1 and 0.6 ng/ml, 1, 4 and 8 h after administration, respectively. A similar pattern of results was observed when F15063 and haloperidol were administered i.p. and s.c., respectively. To summarise, the time-course of D2-like receptor occupancy and inhibition of apomorphine-climbing (and sniffing) behaviours was similarly long lasting with F15063 and haloperidol. In addition, the durations of action of F15063 and haloperidol in a behavioural model of antipsychotic-like activity were closely correlated to their occupancy of central D2-like receptors, and much longer than their presence in plasma.
Collapse
|
20
|
Beulz-Riché D, Grudé P, Puozzo C, Sautel F, Filaquier C, Riché C, Ratanasavanh D. Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine. Fundam Clin Pharmacol 2005; 19:545-53. [PMID: 16176333 DOI: 10.1111/j.1472-8206.2005.00367.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Vinorelbine (VRL) (IV Navelbine) is a semi-synthetic vinca alkaloid, used in therapeutics for the treatment of non-small-cell lung cancer and advanced breast cancer. The aim of this study was to characterize the cytochrome P450 (CYP) isoenzymes involved in VRL metabolism. VRL was incubated at 1.28 x 10(-5) m for 90 min with human hepatic microsomes prepared from 14 donors (one woman and 13 men aged from 27 to 76 years old) and characterized for CYP1A2, CYP2D6, CYP2E1 and CYP3A4 activities. A four-combined-approach study was performed, including correlation between CYP activities and VRL metabolism among the 14 batches of microsomes, inhibition of VRL biotransformation by isoform-selective substrates and by specific inhibitory antibodies, and incubation with supersomes. Analysis of unchanged VRL and its metabolites was performed using an HPLC method coupled with both radioactive and UV detections. No correlation between CYP1A2 or CYP2E1 and VRL metabolism was observed in the 14 batches of microsomes used. A correlation was shown between VRL metabolism and CYP3A4 activity as determined with the dextromethorphan N-demethylase and nifedipine oxidase activities (r(2)=0.80 and 0.59, respectively). These results were strengthened by a correlation between the metabolism extent of VRL and CYP3A4 protein content determined by immunoblotting (r(2)=0.75). Furthermore, VRL biotransformation was inhibited by troleandomycine, the CYP3A4-specific inhibitor substrate (80% of inhibition) and by anti-CYP3A antibodies (36% of inhibition). On the contrary, a low correlation with CYP2D6 activity as determined by dextrometorphan O-demethylation (r(2)=0.31) was established. CYP2D6 supersomes did not metabolize the drug whereas 63.4% of VRL were metabolized by microsomes overexpressing CYP3A4 isoform. These data indicated that CYP3A4 is the main enzyme involved in the hepatic metabolism of VRL in human, whereas CYP2D6 is not involved.
Collapse
Affiliation(s)
- Dominique Beulz-Riché
- Service de Pharmacologie et Pharmacovigilance, CHU Cavale Blanche, 29285 Brest, France
| | | | | | | | | | | | | |
Collapse
|
21
|
Bardin L, Assié MB, Pélissou M, Royer-Urios I, Newman-Tancredi A, Ribet JP, Sautel F, Koek W, Colpaert FC. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. J Pharmacol Exp Ther 2004; 312:1034-42. [PMID: 15528450 DOI: 10.1124/jpet.104.077669] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
The aim of the present study was to establish the relationship between the plasma and brain concentration-time profiles of F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt] after acute administration and both its hyper- and hypoanalgesic effects in rats. The maximal plasma concentration (C(max)) of F 13640 after i.p. administration of 0.63 mg/kg was obtained at 15 min and decreased to half its maximal value after about 1 h. The amount of F 13640 collected by means of in vivo microdialysis in hippocampal dialysates could be measured reliably after 0.63 and 2.5 mg/kg, reached its maximum at about 1 h, and fell to half of its maximal value at about 3 h. 5-Hydroxytryptamine 1A (5-HT(1A)) receptor occupancy was estimated by ex vivo binding in rat brain sections. F 13640 inhibited [(3)H]8-hydroxy-2-[di-n-propylamino] tetralin binding ex vivo in rat hippocampus, entorhinal cortex, and frontal cortex (ED(50), 0.34 mg/kg i.p.). Maximal inhibition was reached at approximately 30 min after 0.63 mg/kg F 13640 and fell to half of its value after about 4 to 8 h. After injection (15 min) in the paw pressure test, F 13640 (0.63 mg/kg i.p.) induced an initial hyperalgesia that was followed 4 h later by a paradoxical analgesia that lasted until 8 h. In contrast, in the formalin test, F 13640 inhibited pain behaviors until 4 h after drug administration. F 13640 also produced elements of the 5-HT syndrome that lasted up to 4 h after administration. These results demonstrate that F 13640 induces hyperalgesia and/or analgesia with a time course that parallels the occupancy of 5-HT(1A) receptors and the presence of the compound in blood and brain.
Collapse
Affiliation(s)
- Laurent Bardin
- Department of General Pharmacology, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres Cedex, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Colpaert FC, Wu WP, Hao JX, Royer I, Sautel F, Wiesenfeld-Hallin Z, Xu XJ. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury. Eur J Pharmacol 2004; 497:29-33. [PMID: 15321732 DOI: 10.1016/j.ejphar.2004.06.026] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2004] [Revised: 05/24/2004] [Accepted: 06/17/2004] [Indexed: 11/17/2022]
Abstract
The selective, high-efficacy 5-HT(1A) receptor agonist, (3-chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl]piperidin-1-yl]-methanone (F 13640) has been reported to produce long-term analgesia in rodent models of chronic nociceptive and neuropathic pain; it also preempts allodynia following spinal cord injury. Here, rats underwent spinal cord injury, fully developed allodynia, and were infused with saline or 0.63 mg/day of F 13640 for 56 days. Infusion was then discontinued, and further assessments of allodynia (vocalization threshold to von Frey filament stimulation, responses to brush and cold) were conducted for another 70 days. F 13640-induced analgesia persisted during this post-treatment period. The data offer initial evidence that high-efficacy 5-HT(1A) receptor activation produces an unprecedented curative-like action on pathological pain.
Collapse
Affiliation(s)
- Francis C Colpaert
- Centre de Recherche Pierre Fabre, 17 Avenue Jean Moulin, 81100 Castres, France.
| | | | | | | | | | | | | |
Collapse
|
23
|
Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999; 400:371-5. [PMID: 10432116 DOI: 10.1038/22560] [Citation(s) in RCA: 471] [Impact Index Per Article: 18.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Environmental stimuli that are reliably associated with the effects of many abused drugs, especially stimulants such as cocaine, can produce craving and relapse in abstinent human substance abusers. In animals, such cues can induce and maintain drug-seeking behaviour and also reinstate drug-seeking after extinction. Reducing the motivational effects of drug-related cues might therefore be useful in the treatment of addiction. Converging pharmacological, human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction. Here we have designed BP 897, the first D3-receptor-selective agonist, as assessed in vitro with recombinant receptors and in vivo with mice bearing disrupted D3-receptor genes. BP 897 is a partial agonist in vitro and acts in vivo as either an agonist or an antagonist. We show that BP 897 inhibits cocaine-seeking behaviour that depends upon the presentation of drug-associated cues, without having any intrinsic, primary rewarding effects. Our data indicate that compounds like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elicited by drug-associated environmental stimuli.
Collapse
MESH Headings
- Animals
- Behavior, Addictive
- CHO Cells
- Cell Line
- Cocaine-Related Disorders/drug therapy
- Cocaine-Related Disorders/metabolism
- Cocaine-Related Disorders/psychology
- Corpus Striatum/drug effects
- Corpus Striatum/metabolism
- Cricetinae
- Dopamine Agonists/pharmacology
- Genes, fos
- Humans
- Male
- Mice
- Piperazines/pharmacology
- Rats
- Rats, Wistar
- Receptors, Dopamine D1/agonists
- Receptors, Dopamine D1/antagonists & inhibitors
- Receptors, Dopamine D1/metabolism
- Receptors, Dopamine D2/agonists
- Receptors, Dopamine D2/genetics
- Receptors, Dopamine D2/metabolism
- Receptors, Dopamine D3
- Recombinant Proteins/metabolism
- Reinforcement, Psychology
- Self Administration
Collapse
Affiliation(s)
- M Pilla
- Department of Experimental Psychology, University of Cambridge, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
In an association study of the Bal I polymorphism in the dopamine D3 receptor (DRD3) gene in a French Caucasian population, global comparison of patients with schizophrenia (n = 89, DSM-III-R criteria) and controls (n = 52) led to non-significant differences. However, the homozygosity was significantly more frequent in schizophrenic patients with lifetime substance abuse comorbidity (n = 36) as compared to patients with no history of substance abuse (P = 0.010) or to controls (P = 0.047) and in neuroleptic responder patients as compared to treatment-refractory patients (n = 19; P = 0.037). The combined characteristics treatment response and lifetime substance abuse were strongly associated with homozygosity. We propose that homozygosity for the Bal I polymorphism DRD3 gene is associated with predisposition to substance abuse and/or the pharmacosensitive characteristic of schizophrenia rather than with schizophrenia itself, an hypothesis in agreement with the positive association of this polymorphism with opiate dependence (see companion article by Duaux et al) and the involvement of DRD3 in both pharmacodependence mechanisms and antipsychotic effects of neuroleptics.
Collapse
Affiliation(s)
- M O Krebs
- Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique, Hôpital Sainte-Anne, Université René Descartes, Paris V, France.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Duaux E, Gorwood P, Griffon N, Bourdel MC, Sautel F, Sokoloff P, Schwartz JC, Ades J, Lôo H, Poirier MF. Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry 1998; 3:333-6. [PMID: 9702742 DOI: 10.1038/sj.mp.4000409] [Citation(s) in RCA: 76] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Anatomical, pharmacological and human post-mortem studies suggest the dopamine D3 receptor (DRD3) gene as a candidate for drug dependence. We thus performed an association study of the Bal I polymorphism at the DRD3 gene, including 54 opiate addicts and 70 controls. Opiate addicts had a higher sensation-seeking score (on the Zückerman scale) than controls (P = 0.001), particularly a subgroup (70%) who had a distinctly higher score, exceeding 24. There were no marked differences in genotypes between patients as a whole and controls. However, patients with a sensation-seeking score above 24 were more frequently homozygotes for both alleles than patients with a sensation-seeking score under 24 (P = 0.038) or controls (P = 0.034). Although obtained in a sample of limited size, these results suggest that the DRD3 gene may have a role in drug dependence susceptibility in individuals with high sensation-seeking scores. This hypothesis is consistent with the role of DRD3 in mediating responses to drugs of abuse in animals and the association of homozygosity at the Bal I polymorphism with drug abuse in schizophrenic patients (see companion article by Krebs et al).
Collapse
Affiliation(s)
- E Duaux
- Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique, Université René Descartes, Hôpital Sainte-Anne, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP. J Neurochem 1997; 68:1-9. [PMID: 8978703 DOI: 10.1046/j.1471-4159.1997.68010001.x] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
As cerebral neurons express the dopamine D1 receptor positively coupled with adenylyl cyclase, together with the D3 receptor, we have investigated in a heterologous cell expression system the relationships of cyclic AMP with D3 receptor signaling pathways. In NG108-15 cells transfected with the human D3 receptor cDNA, dopamine, quinpirole, and other dopamine receptor agonists inhibited cyclic AMP accumulation induced by forskolin. Quinpirole also increased mitogenesis, assessed by measuring [3H]thymidine incorporation. This effect was blocked partially by genistein, a tyrosine kinase inhibitor. Forskolin enhanced by 50-75% the quinpirole-induced [3H]thymidine incorporation. This effect was maximal with 100 nM forskolin, occurred after 6-16 h, was reproduced by cyclic AMP-permeable analogues, and was blocked by a protein kinase A inhibitor. Forskolin increased D3 receptor expression up to 135%, but only after 16 h and at concentrations of > 1 microM. Thus, in this cell line, the D3 receptor uses two distinct signaling pathways: it efficiently inhibits adenylyl cyclase and induces mitogenesis, an effect possibly involving tyrosine phosphorylation. Activation of the cyclic AMP cascade potentiates the D3 receptor-mediated mitogenic response, through phosphorylation by a cyclic AMP-dependent kinase of a yet unidentified component. Hence, transduction of the D3 receptor can involve both opposite and synergistic interactions with cyclic AMP.
Collapse
Affiliation(s)
- N Griffon
- Unité de Neurobiologie et Pharmacologie, Centre Paul Broca de l'INSERM, Paris, France
| | | | | | | | | |
Collapse
|
27
|
Griffon N, Sautel F, Pilon C, Lévesque D, Sokoloff P, Schwartz JC, Diaz J, Simon P, Costentin J, Mann A, Wermuth CG. Functional models for the dopamine D3 receptor. Biochem Soc Trans 1996; 24:193-8. [PMID: 8674660 DOI: 10.1042/bst0240193] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- N Griffon
- Unité de Neurobiologie et Pharmacologie, Centre Paul Broca de I'INSERM, Paris, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P. Antipsychotics with inverse agonist activity at the dopamine D3 receptor. J Neural Transm (Vienna) 1996; 103:1163-75. [PMID: 9013403 DOI: 10.1007/bf01271201] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
In NG 108-15 cells expressing the recombinant human D3 receptor, dopamine agonists enhance [3H]thymidine incorporation and decrease cAMP accumulation. In these cells, but not in wild type cells, haloperidol, fluphenazine, and various other antipsychotics inhibited basal [3H]thymidine incorporation in a concentration-dependent manner. In contrast, other dopamine antagonists such as nafadotride or (+)AJ 76, two D3-preferring antagonists, were without effect. The concentration-response curve of haloperidol was shifted to the right in presence of nafadotride, with a potency compatible with its nanomolar apparent affinity as neutral antagonist. Pertussis toxin treatment abolished or markedly reduced the responses to haloperidol or fluphenazine. In contrast, no significant enhancement of cAMP accumulation could be observed, under the influence of haloperidol or eticlopride. These data indicate that some dopamine antagonists behave as inverse agonists, and thus appear to inhibit an agonist-independent activity of the D3 receptor on [3H]thymidine incorporation pathway, but not on the cAMP pathway.
Collapse
Affiliation(s)
- N Griffon
- Unité de Neurobiologie et Pharmacologie de l'INSERM, Centre Paul Broca, Paris, France
| | | | | | | | | |
Collapse
|
29
|
Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 1995; 275:1239-46. [PMID: 8531087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Nafadotride (N[(n-butyl-2-pyrrolidinyl)methyl]-1-methoxy-4-cyano naphtalene-2-carboxamide) is a novel compound, which inhibits potently and stereoselectively [125I]iodosulpride binding at recombinant human dopamine D3 receptors. the levoisomer displays an apparent Ki value of 0.3 nM at the dopamine D3 receptor, but is 10 times less potent at the human recombinant dopamine D2 receptor. In comparison, the dextroisomer displays 20-fold less apparent affinity at the dopamine D3 receptor and reduced (2-fold) selectivity. l-Nafadotride displays iow, micromolar affinity at dopamine D1 and D4 receptors and negligible apparent affinity at various other receptors. In dopamine D3 receptor-transfected NG-108 15 cells, in which dopamine agonists increase mitogenesis, l-nafadotride has no intrinsic activity, but competitively antagonizes the quinpirole-induced mitogenetic response, monitored by [3H]thymidine incorporation with a pA2 of 9.6. In dopamine D2 receptor-transfected Chinese Hamster Ovary cells, l-nafadotride also behaves as a competitive antagonist of quinpirole-induced mitogenesis with an 11-fold lower potency. These studies establish nafadotride as a pure, extremely potent, competitive and preferential dopamine D3 receptor antagonist in vitro. l-Nafadotride displaces in vivo N-[3H]propylnorapomorphine accumulation at lower dosage and for longer periods in limbic structures, containing both dopamine D2 and D3 receptors than in the stratum, containing dopamine D2 receptor only. At low dosage (0.1-1 mg/kg), nafadotride, unlike haloperidol, a dopamine D2 receptor-preferring antagonist, increases spontaneous locomotion of habituated rats and climbing behavior of mice, at doses that do not modify striatal homovanillic acid levels. At high dosage (1-100 mg/kg), nafadotride, like haloperidol, produces catalepsy and antagonizes apomorphine-induced climbing.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- F Sautel
- Unité de Neurobiogie et Pharmacologie, Centre Paul Broca de l'Institut National de la Santé et de la Recherche Médicale, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Schwartz JC, Griffon N, Diaz J, Levesque D, Sautel F, Sokoloff P, Simon P, Costentin J, Garrido F, Mann A. The D3 receptor and its relevance in psychiatry. Int Clin Psychopharmacol 1995; 10 Suppl 3:15-20. [PMID: 8866761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
A large fraction of neurotensin neurons in the ventromedial shell subdivision of nucleus accumbens express D3 receptors. Blockade of D2/D3 receptors by antipsychotic agents paradoxically decreases neurotensin gene expression in these neurons whereas it enhances it in other striatal areas expressing the D2 receptor. This suggests that D2 and D3 receptors mediate opposite actions of dopamine. In support of this view low doses of nafadotride, a novel D3 receptor-preferring antagonist, enhances locomotor activity in rodents, a behavioral response opposite to that of current neuroleptics. The action of D3 receptor-preferring agonists was characterized by the mitogenic response they elicit in transfected NG 108-15 cells. Finally, gene expression of the D3 receptor is in opposition to that of the D2 receptor, being decreased by denervation and unaffected by chronic blockade by neuroleptics.
Collapse
Affiliation(s)
- J C Schwartz
- Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Centre Paul Broca, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Abstract
The functional potency of a series of dopamine agonists for increasing mitogenesis, measured by incorporation of [3H]thymidine, was established in transfected cell lines expressing human D2 or D3 receptors. The functional selectivity of agonists markedly differs from their binding selectivity. (+)7-OH-DPAT, pramipexole, quinerolane and PD 128,907, the most D3 receptor-selective compounds in binding studies, were 7, 15, 21 and 54 times more potent, respectively, at the D3 than at the D2 receptor in the functional test. Bromocriptine displayed a 10-fold functional selectivity toward the D2 receptor. The known behavioural actions of D3 selective agonists support a role for the D3 receptor in motor inhibitions, which should be taken into account for the treatment of motor dysfunctions by dopamine agonists.
Collapse
Affiliation(s)
- F Sautel
- Unité de Neurobiologie et Pharmacologie, Centre Paul Broca de l'INSERM, Paris, France
| | | | | | | | | | | |
Collapse
|
32
|
Griffon N, Sokoloff P, Diaz J, Lévesque D, Sautel F, Schwartz JC, Simon P, Costentin J, Garrido F, Mann A. The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches. Eur Neuropsychopharmacol 1995; 5 Suppl:3-9. [PMID: 8775753 DOI: 10.1016/0924-977x(95)00030-s] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Antipsychotic drug therapy mainly rests on the use of antagonists of dopamine D2-like (D2, D3 and D4) receptors, for which all clinically active compounds have high affinity. The D3 receptor has a restricted expression in brain limbic areas, associated with cognitive functions and motivated behavior. D3 selective agonists and antagonists reveal an inhibitory role on motor behaviors for the D3 receptor, opposite to that of the D2 receptor. An opposing role for D2 and D3 receptors is also suggested by the contrasted effects of D2/D3 antagonists on neurotensin expression in discrete subdivisions of nucleus accumbens, where D2 and D3 receptors are selectively expressed. Tolerance to the motor but not to the therapeutic effects of neuroleptics is observed after repeated administration, which upregulates the D2, but not the D3 receptor in animals. In genetic association studies, an excess of homozygosity for both alleles of the BalI polymorphism at the D3 receptor gene was found in schizophrenic patients, suggesting that this gene may have subtle influence on the liability to develop schizophrenia. These results suggest the D3 receptor as an important target for antipsychotic drug action, and D3 receptor selective antagonists as promising therapeutic agents.
Collapse
Affiliation(s)
- N Griffon
- Unité de Neurobiologie et Pharmacologie (U. 109) de l'INSERM, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|